earticle

영어

Anxiety is common emotions in predialysis patients with chronic kidney disease (CKD). The purpose of this study was to measure the anxiety in predialysis patients and to identify clinical variables that are associated with anxiety. The subjects for this study were 102 patients who visited the nephrology outpatient department of a tertiary hospital in Seoul between October 12th and October 26th, 2013 and consented to participate in the study. The collected data were analyzed by the SPSS WIN 12.0 program. The mean score of anxiety was 12.2 which means their experience of high level anxiety and moderate and severe symptoms of anxiety were identified in 59.8% of the patients. There were significantly negative correlations between anxiety and residual renal function (r=-.221, p=.026). There was a significant difference in the anxiety of the subjects at each stage (F=4.54, p=.013). The Scheffe post hoc test confirmed that patients at Stage 5 had highest levels of anxiety. There were significantly positive correlations between anxiety and uremic symptoms (r=.481, p<.001). There were significantly negative correlations between anxiety and age (r=-.201, p=.045) and comorbidities (r=-.218, p=.028). Also, Age, GFRs, comorbidities and uremic symptoms predicted value accounted for 57.2% of the variance on anxiety (F=11.77, p<.001). Hence, health care providers should be concerned about helping to slow the progression of renal failure and considered related variables when planning an approach towards managing the anxiety in predialysis patients with CKD.